Singular Genomics Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '21 Sep 30, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Revenue	1.94	4.61	5.37	0.73	0.39	0.48
Revenue Growth (YoY)	-72.87%	-14.09%	633.40%	85.81%	-18.05%	-
Cost of Revenue	1.55	3.23	3.66	0.76	0.26	0.44
Gross Profit	0.39	1.38	1.71	-0.03	0.14	0.04
Selling, General & Admin	-0.42	2.11	4.18	4.68	5.69	1.14
Research & Development	0.03	0.1	0.03	0.07	-	-
Operating Expenses	0.21	3.67	8.65	7.77	5.75	1.18
Operating Income	0.18	-2.29	-6.94	-7.79	-5.62	-1.14
Interest Expense	-0.19	-0.21	-0.22	-0.01	-0.25	-0.09
Interest & Investment Income	0	0	0.02	-	-	-
Currency Exchange Gain (Loss)	-0	-0	0	-	-	-
Other Non Operating Income (Expenses)	-0.03	-1.01	-	0.05	-	-
EBT Excluding Unusual Items	-0.05	-3.51	-7.14	-7.75	-5.86	-1.23
Merger & Restructuring Charges	-	-	-	-3.38	-	-
Impairment of Goodwill	-	-	-5.56	-	-	-
Gain (Loss) on Sale of Investments	-	-	-1.12	-0.99	-	-
Gain (Loss) on Sale of Assets	1.68	1.68	-	-	-	-
Asset Writedown	-1.99	-1.99	-3.82	-	-	-
Legal Settlements	-0.18	-0.18	-	-	-	-
Other Unusual Items	0.17	0.03	-	-3.57	-	-
Pretax Income	-0.37	-3.96	-17.63	-15.7	-5.86	-1.23
Net Income	-0.37	-3.96	-17.63	-15.7	-5.86	-1.23
Net Income to Common	-0.37	-3.96	-17.63	-15.7	-5.86	-1.23
Shares Outstanding (Basic)	51	49	43	14	6	2
Shares Outstanding (Diluted)	51	49	43	14	6	2
Shares Change (YoY)	7.51%	13.12%	201.33%	136.49%	142.58%	-
EPS (Basic)	-0.01	-0.08	-0.41	-1.10	-0.97	-0.49
EPS (Diluted)	-0.01	-0.08	-0.41	-1.10	-0.97	-0.49
Free Cash Flow	0.21	-0.31	-2.43	-2.09	-1.75	-0.7
Free Cash Flow Per Share	0.00	-0.01	-0.06	-0.15	-0.29	-0.28
Gross Margin	20.19%	29.93%	31.87%	-3.80%	34.89%	7.61%
Operating Margin	9.29%	-49.59%	-129.19%	-1064.40%	-1424.87%	-237.12%
Profit Margin	-18.81%	-85.86%	-328.33%	-2144.60%	-1487.38%	-254.89%
Free Cash Flow Margin	10.61%	-6.72%	-45.24%	-284.82%	-443.41%	-144.77%
EBITDA	0.59	-1.73	-5.81	-7.61	-5.55	-1.1
EBITDA Margin	30.41%	-37.60%	-108.28%	-	-	-229.19%
D&A For EBITDA	0.41	0.55	1.12	0.18	0.07	0.04
EBIT	0.18	-2.29	-6.94	-7.79	-5.62	-1.14
EBIT Margin	9.29%	-49.59%	-129.19%	-	-	-237.12%
Revenue as Reported	1.94	4.61	5.37	0.73	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q